Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 35% ± 20% | |
| GABAergic neuron | 4 studies | 43% ± 12% | |
| type B pancreatic cell | 3 studies | 54% ± 29% | |
| neuron | 3 studies | 20% ± 4% | |
| retinal ganglion cell | 3 studies | 44% ± 17% | |
| enteroendocrine cell | 3 studies | 31% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 90% | 1087.48 | 80 / 89 | 78% | 47.39 | 705 / 901 |
| pancreas | 49% | 346.39 | 162 / 328 | 90% | 56.92 | 161 / 178 |
| brain | 88% | 4755.00 | 2336 / 2642 | 51% | 17.00 | 359 / 705 |
| stomach | 65% | 615.06 | 235 / 359 | 71% | 26.31 | 203 / 286 |
| intestine | 52% | 677.96 | 504 / 966 | 75% | 26.62 | 397 / 527 |
| prostate | 32% | 245.44 | 78 / 245 | 40% | 8.81 | 200 / 502 |
| thymus | 32% | 228.50 | 210 / 653 | 30% | 5.63 | 180 / 605 |
| heart | 54% | 555.88 | 468 / 861 | 0% | 0 | 0 / 0 |
| breast | 0% | 1.65 | 1 / 459 | 52% | 46.86 | 581 / 1118 |
| ovary | 1% | 1.93 | 1 / 180 | 50% | 7.13 | 215 / 430 |
| adrenal gland | 11% | 93.75 | 28 / 258 | 39% | 17.48 | 90 / 230 |
| esophagus | 0% | 0.61 | 2 / 1445 | 37% | 14.08 | 67 / 183 |
| lung | 2% | 7.45 | 9 / 578 | 27% | 9.64 | 313 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 24% | 7.43 | 120 / 504 |
| uterus | 1% | 3.69 | 1 / 170 | 21% | 4.15 | 97 / 459 |
| liver | 0% | 1.53 | 1 / 226 | 16% | 13.56 | 63 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.44 | 2 / 45 |
| skin | 1% | 3.65 | 11 / 1809 | 3% | 0.40 | 13 / 472 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.26 | 2 / 80 |
| blood vessel | 0% | 1.10 | 3 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.95 | 2 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.49 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0017156 | Biological process | calcium-ion regulated exocytosis |
| GO_0070382 | Cellular component | exocytic vesicle |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030133 | Cellular component | transport vesicle |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0000149 | Molecular function | SNARE binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0001786 | Molecular function | phosphatidylserine binding |
| GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
| Gene name | SYT13 |
| Protein name | Synaptotagmin 13 Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII) |
| Synonyms | KIAA1427 |
| Description | FUNCTION: May be involved in transport vesicle docking to the plasma membrane. . |
| Accessions | Q7L8C5 ENST00000533332.1 H0YE47 H0YD47 ENST00000528101.1 ENST00000020926.8 |